1-20644665-A-T
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting
The NM_032409.3(PINK1):c.952A>T(p.Met318Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000737 in 1,614,172 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_032409.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PINK1 | ENST00000321556.5 | c.952A>T | p.Met318Leu | missense_variant | Exon 4 of 8 | 1 | NM_032409.3 | ENSP00000364204.3 | ||
PINK1 | ENST00000492302.1 | n.2040A>T | non_coding_transcript_exon_variant | Exon 2 of 5 | 2 | |||||
PINK1-AS | ENST00000451424.1 | n.3981+920T>A | intron_variant | Intron 2 of 2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000861 AC: 131AN: 152222Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000900 AC: 226AN: 251094Hom.: 1 AF XY: 0.000847 AC XY: 115AN XY: 135776
GnomAD4 exome AF: 0.000724 AC: 1058AN: 1461832Hom.: 1 Cov.: 31 AF XY: 0.000688 AC XY: 500AN XY: 727224
GnomAD4 genome AF: 0.000860 AC: 131AN: 152340Hom.: 0 Cov.: 33 AF XY: 0.000872 AC XY: 65AN XY: 74502
ClinVar
Submissions by phenotype
not provided Uncertain:5
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 16755580, 22118943, 15970950, 22644621, 18330912, 19351622, 16547921, 22243833, 27094865, 15596610, 21412950, 34426522, 27393345, 24660942, 30665447, 33921279, 35954270) -
PINK1: PM2 -
- -
- -
BS1 -
Autosomal recessive early-onset Parkinson disease 6 Uncertain:5
- -
- -
This sequence change replaces methionine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 318 of the PINK1 protein (p.Met318Leu). This variant is present in population databases (rs139226733, gnomAD 0.3%), including at least one homozygous and/or hemizygous individual. This missense change has been observed in individual(s) with in the heterozygous state in several individuals affected with late onset Parkinson's disease (PMID: 15596610, 16755580, 19351622, 22243833, 24660942, 27094865). ClinVar contains an entry for this variant (Variation ID: 447942). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PINK1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
- -
not specified Uncertain:2
- -
Variant summary: PINK1 c.952A>T (p.Met318Leu) results in a conservative amino acid change located in the Protein kinase domain profile domain (IPR000719) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0009 in 251094 control chromosomes in the gnomAD database, including 1 homozygotes. This frequency is not significantly higher than estimated for a pathogenic variant in PINK1 causing Autosomal Recessive Early-Onset Parkinson Disease 6, allowing no conclusion about variant significance. c.952A>T has been reported in the literature in the heterozygous state individuals affected with Parkinson Disease in conjunction with other variants in Parkinson Disease-related genes in some cases (Brooks_2009, Djarmati_2006, Rogaeva_2004, Diez-Fairen_2018, Landoulsi_2023, Farlow_2016, Pihlstrom_2014). These report(s) do not provide unequivocal conclusions about association of the variant with Autosomal Recessive Early-Onset Parkinson Disease 6. At least one publication reports experimental evidence that this variant resulted in no PINK1 auto-phosphorylation in vitro, indicating a loss of kinase activity, while overall protein levels of PINK1 remained relatively unchanged. These reults do not allow convincing conclusions about the variant effect (Broadway_2022). The following publications have been ascertained in the context of this evaluation (PMID: 35954270, 19351622, 29887346, 16755580, 26595808, 38173558, 24660942, 15596610). ClinVar contains an entry for this variant (Variation ID: 447942). Based on the evidence outlined above, the variant was classified as uncertain significance. -
PINK1-related disorder Uncertain:1
The PINK1 c.952A>T variant is predicted to result in the amino acid substitution p.Met318Leu. This variant has been reported in the heterozygous state in multiple individuals with both late- and early-onset Parkinson's disease (Rogaeva et al. 2004. PubMed ID: 15596610; Djarmati et al. 2006. PubMed ID: 16755580; Brooks et al. 2009. PubMed ID: 19351622; Pihlstrøm et al. 2014. PubMed ID: 24660942; Bandrés-Ciga et al. 2016. PubMed ID: 27393345; Kuzkina et al. 2022. PubMed ID: 37248217). In vitro functional studies have shown that this variant leads to a loss of PINK1 phosphorylation activity (Broadway et al. 2022. PubMed ID: 35954270). This variant is reported in 0.25% of alleles in individuals of Ashkenazi Jewish descent in gnomAD, including one homozygote. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at